NCT05168657 - Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

May 23, 2023

Study Completion Date

May 23, 2023

Conditions

Diabetes Mellitus, Type 1Type 1 DiabetesDiabetes, AutoimmuneDiabetes type1Autoimmune DiabetesDiabetes Mellitus, BrittleDiabetes Mellitus, Insulin-DependentDiabetes Mellitus, Insulin-Dependent, 1Diabetes Mellitus, Juvenile-OnsetDiabetes Mellitus, Ketosis-ProneDiabetes Mellitus, Sudden-OnsetInsulin-Dependent Diabetes Mellitus 1Juvenile-Onset DiabetesType 1 Diabetes Mellitus

Interventions

DEVICE

Bionic Pancreas

14 days using the insulin-only configuration of the iLet Bionic Pancreas (Beta Bionics, Inc.), which automates insulin delivery, as the only intended mode of insulin delivery.

OTHER

Usual Care

14 days of the participant's usual care of their type 1 diabetes

Trial Locations (2)

80045

University of Colorado Anschutz Medical Campus, Aurora

02114

Massachusetts General Hospital, Boston